Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Treasury Shares (2018 - 2025)

Revolution Medicines (RVMD) has 7 years of Treasury Shares data on record, last reported at $3.9 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 36.56% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, up 36.56%, while the annual FY2025 figure was $3.9 million, 36.56% up from the prior year.
  • Treasury Shares reached $3.9 million in Q4 2025 per RVMD's latest filing, up from $3.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.9 million in Q4 2025 and bottomed at $272.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $1.8 million, with a median of $1.6 million recorded in 2022.
  • Peak YoY movement for Treasury Shares: crashed 99.97% in 2023, then surged 1102504.81% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $5793.0 in 2021, then tumbled by 95.3% to $272.0 in 2022, then grew by 6.99% to $291.0 in 2023, then skyrocketed by 979319.93% to $2.9 million in 2024, then surged by 36.56% to $3.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $3.9 million in Q4 2025, $3.8 million in Q3 2025, and $3.8 million in Q2 2025.